{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:31:25Z","timestamp":1787391085965,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.diagmicrobio.2026.117270","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T23:33:31Z","timestamp":1768088011000},"page":"117270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aspergillus fumigatus brain abscess in an immunocompromised patient receiving a second-generation Bruton Tyrosine Kinase inhibitor (BTKi)"],"prefix":"10.1016","volume":"114","author":[{"given":"Marios","family":"Lampros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Kittas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Kafritsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0257-4481","authenticated-orcid":false,"given":"George A.","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Voulgaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117270_bib0001","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa2211582","article-title":"Zanubrutinib or Ibrutinib in relapsed or refractory chronic lymphocytic leukemia","volume":"388","author":"Brown","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2026.117270_bib0002","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117270_bib0003","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/hematology.2020000118","article-title":"Managing toxicities of Bruton tyrosine kinase inhibitors","volume":"2020","author":"Lipsky","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117270_bib0004","doi-asserted-by":"crossref","first-page":"ofae115","DOI":"10.1093\/ofid\/ofae115","article-title":"Risk of invasive fungal infections in patients with chronic lymphocytic leukemia treated with bruton tyrosine kinase inhibitors: a case-control propensity score\u2013matched analysis","volume":"11","author":"Higuita","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"17","key":"10.1016\/j.diagmicrobio.2026.117270_bib0005","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood-2017-11-818286","article-title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib","volume":"131","author":"Ghez","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.diagmicrobio.2026.117270_bib0006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mmcr.2019.12.007","article-title":"A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy","volume":"27","author":"Eichenberger","year":"2019","journal-title":"Med Mycol Case Rep"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117270_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12879-020-4894-2","article-title":"Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: a case report","volume":"20","author":"Le","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117270_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01263","article-title":"Cerebral aspergillosis and facial acneiform lesions following initiation of ibrutinib in a patient with chronic lymphocytic leukemia","volume":"26","author":"Bedier","year":"2021","journal-title":"IDCases"},{"key":"10.1016\/j.diagmicrobio.2026.117270_bib0009","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.medmal.2018.01.003","article-title":"Cerebral aspergillosis: an emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?","volume":"48","author":"Gaye","year":"2018","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.diagmicrobio.2026.117270_bib0010","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1080\/10428194.2017.1320710","article-title":"Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis","volume":"58","author":"Baron","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117270_bib0011","doi-asserted-by":"crossref","first-page":"e7564","DOI":"10.1002\/ccr3.7564","article-title":"Disseminated fungal infection in a patient receiving zanubrutinib","volume":"11","author":"Walsh","year":"2023","journal-title":"Clin Case Rep"},{"issue":"17_supplement_2","key":"10.1016\/j.diagmicrobio.2026.117270_bib0012","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000203281","article-title":"CNS aspergillosis following BTK inhibitors mimicking Secondary CNS lymphoma \u2013 a case Series (P14-13.004)","volume":"100","author":"Murthy","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117270_bib0013","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41420-022-00927-4","article-title":"Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease","volume":"8","author":"Yin","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.diagmicrobio.2026.117270_bib0014","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3389\/fimmu.2020.02158","article-title":"BTK inhibition impairs the innate response against fungal infection in patients with chronic lymphocytic leukemia","volume":"11","author":"Fiorcari","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117270_bib0015","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176142","article-title":"BTK drives neutrophil activation for sterilizing antifungal immunity","volume":"134","author":"Desai","year":"2024","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117270_bib0016","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/ciab1026","article-title":"Incidence of invasive fungal infections in patients initiating ibrutinib and other small molecule kinase inhibitors\u2014united states, July 2016\u2013June 2019","volume":"75","author":"Gold","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.diagmicrobio.2026.117270_bib0017","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2017-12-823393","article-title":"Ibrutinib blocks Btk-dependent NF-\u0138B and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis","volume":"132","author":"Bercusson","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.diagmicrobio.2026.117270_bib0018","article-title":"Cerebral Aspergillosis: diagnostic challenges, therapeutic strategies, and future research","author":"Chantelot","year":"2025","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117270_bib0019","doi-asserted-by":"crossref","first-page":"E174","DOI":"10.1002\/ajh.25816","article-title":"Second generation BTK inhibitors impair the anti-fungal response of macrophages and neutrophils","volume":"95","author":"Colado","year":"2020","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117270_bib0020","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.176162","article-title":"BTK inhibitor-induced defects in human neutrophil effector activity against Aspergillus fumigatus are restored by TNF-\u03b1","volume":"9","author":"Vargas-Blanco","year":"2024","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117270_bib0021","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/curroncol28010081","article-title":"Cerebral Invasive Aspergillosis in a case of chronic lymphocytic leukemia with bruton tyrosine kinase inhibitor","volume":"28","author":"Alkharabsheh","year":"2021","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117270_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2024-261036","article-title":"Cerebral aspergillosis in a patient with chronic lymphocytic leukaemia complicated by Evans syndrome","volume":"18","author":"Elyas","year":"2025","journal-title":"BMJ Case Rep"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:30:52Z","timestamp":1774427452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889326000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0732889326000209"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117270","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspergillus fumigatus brain abscess in an immunocompromised patient receiving a second-generation Bruton Tyrosine Kinase inhibitor (BTKi)","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117270"}}